Personalised approach to treating early Hodgkin’s lymphomaBMJ 2015; 350 doi: https://doi.org/10.1136/bmj.h2927 (Published 02 June 2015) Cite this as: BMJ 2015;350:h2927
- Tim Illidge, professor of clinical oncology1
- 1Institute of Cancer Sciences, University of Manchester, RRR Dept 58, Christie NHS Foundation Trust, Withington M20 4BX, UK
As a coauthor of the original paper, I read the research news article “PET after chemotherapy identifies Hodgkin’s lymphoma patients who can avoid radiotherapy” with interest.1 The title grossly over-simplifies the increasingly challenging personalised decision making needed in responding to a “negative” positron emission tomography scan after initial chemotherapy in early Hodgkin’s lymphoma. The decision about whether to omit radiotherapy …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial